CBER director Karim Mikhail and Alliance for Regenerative Medicine (ARM) CEO Tim Hunt discussed updated CGT industry growth ...

A massive genomic study of 904 sorghum varieties reveals that grain filling duration and kernel weight share overlapping ...

Discover how a new Stanford study reveals surprising, personalized blood sugar responses—and why fiber, potatoes, or grapes ...

ATSN-201 demonstrated structural and functional benefit in Parts A and B, including microperimetry improvements exceeding the level the FDA has ...

The FDA has approved 'Otarmeni', the first gene therapy for congenital hearing loss (DFNB9) caused by OTOF gene mutations.It ...

Researchers identified the GRAS transcription factor PmGRAS8 as a candidate activator of the phosphate-responsive PmSPX1 ...

The effects of disease-associated genetic variants on gene expression and genome accessibility have been analysed together.

Controlling brain neurons with light.The discovery leading to this technology was awarded the 2026 Nobel Prize in Physiology ...

Infertility affects more than 15% of couples worldwide. Thanks to medical science, infertility treatments have come a long ...

There was a moment in Nebraska's game against Maryland where quarterback Anthony Colandrea's chaos gene was on full display. The Cornhuskers quarterback took the snap on a designe ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

Perceive Biotherapeutics, Inc. ("Perceive Bio" or the "Company"), a biotechnology company advancing novel gene therapies in ophthalmology ...